Allogene Therapeutics (ALLO) Other Non-Current Liabilities (2018 - 2026)
Allogene Therapeutics (ALLO) recorded Other Non-Current Liabilities of $11.84 million in Q2 2026, down 21.7% from $15.12 million a year earlier and down 26.6% from the prior quarter.
Allogene Therapeutics (ALLO) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
At the end of FY2025, Allogene Therapeutics reported Other Non-Current Liabilities of $15.8 million, up 103.6% from FY2024.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 38.7% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Liabilities came in at $7.76 million in FY2024 (+49.9%), $5.18 million in FY2023 (-11.4%), $5.85 million in FY2022 (-25.0%) and $7.79 million in FY2021 (+152.7%).
- The Q2 2026 figure is the lowest quarterly Other Non-Current Liabilities since Q1 2025.
- On a year-over-year basis, Other Non-Current Liabilities rose in seven of the last eight quarters, with growth averaging 67.8%.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 156.9% in Q1 2022, against a decline of 27.4% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $16.12 million (Q1 2026), $15.8 million (Q4 2025) and $15.48 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Allogene Therapeutics | 322.04 Mn | -820.62 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.23 Mn |
| Jun 30, 2026 | 11.84 Mn |
| Mar 31, 2026 | 16.12 Mn |
| Dec 31, 2025 | 15.80 Mn |
| Sep 30, 2025 | 15.48 Mn |
| Jun 30, 2025 | 15.12 Mn |
| Mar 31, 2025 | 11.28 Mn |
| Dec 31, 2024 | 7.76 Mn |
| Sep 30, 2024 | 7.67 Mn |
| Jun 30, 2024 | 7.55 Mn |
| Mar 31, 2024 | 5.17 Mn |
| Dec 31, 2023 | 5.18 Mn |
| Sep 30, 2023 | 5.19 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 5.21 Mn |
| Dec 31, 2022 | 5.85 Mn |
| Sep 30, 2022 | 6.29 Mn |
| Jun 30, 2022 | 6.73 Mn |
| Mar 31, 2022 | 7.17 Mn |
| Dec 31, 2021 | 7.79 Mn |
Allogene Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ALLO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();